Published On Apr 3, 2023
NEXT SUPER STOCK Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) Phase 2A Clinical Trials for Psilocybin therapeutic for Autism FXS starting! Interview with Andrew Charrette, Director Regulatory Affairs at KGK Science which will be running the clinical trial and Dr. Marvin Hausmann, Chief Medical Officer at NMLSF.
Get TEN BAGGER BLUEPRINT on Amazon: https://tinyurl.com/4pmeuf9a
www.TenBaggerBlueprint.com
Join our TELEGRAM channel: https://t.me/s/WallStreetReporter
🖥 Website: http://www.WallStreetReporter.com
Terms of Use & SEC 17B disclosure: : https://tinyurl.com/2x4eznd5
Main channel:    • NEXT SUPER STOCK 💰🚀 Nova Mentis Life ... Â
We talk about cheap penny stocks with EXPLOSIVE 🧨 🚀 UPSIDE POTENTIAL YES!! Could could be our next 20X🚀 50X🚀 winners like $PKK $CBDT $VSBY $FANS etc. which we brought you at ground floor! Don't FOMO later when the rocket is midway to "Planet TenBagger" ! !
